Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors
Sign Up to like & getrecommendations! Published in 2021 at "Parkinson's Disease"
DOI: 10.1155/2021/9952743
Abstract: Objective To investigate the use of dopamine agonists and monoamine oxidase type B (MAO-B) inhibitors in the Norwegian population, between 1 July 2006 and 31 December 2016. Our primary endpoint was time until need for… read more here.
Keywords: mao inhibitor; dopamine agonists; mao inhibitors; dopamine agonist ... See more keywords